Find out more about how we meet the challenges of research, development and manufacturing data management.
Accelerating tech transfer is vital with new precision medicine and increasing regulatory scrutiny of product quality and management of external partners.
Come and join us at PEGS Boston, booth 302, to learn how Polar workflows simplify the BioPharma lifecycle with process-aware planning, design and execution of end-to-end bioprocess and analytics unit operations.
In this webinar, we share:
How a holistic process-centric approach to data capture can ensure data is aligned and contextualized to generate meaningful insight for confident decisions
How to build deeper understanding of process variables to unlock mysteries, ensure consistency where it matters most and open the door to more rapid process design
How easy-to-use visualization tools and advanced analytics linked to a digital data backbone can streamline process optimization
Come and join us at ABS, booth 44, to learn how Skyland PIMS can help improve your team’s operational efficiency via a single source for simplified process monitoring.
IDBS and SciBite announce a new partnership to shift the way research data platforms approach FAIR (Findable, Accessible, Interoperable, and Reusable) data.
IDBS announces the launch of new data science capabilities for its Polar platform to accelerate BioPharma process optimization.
Meet and speak to our experts to learn how our cloud-native Skyland PIMS software helps both sponsors and CMOs/CDMOs seamlessly share processes and process data in the same environment. Data can be securely and instantly shared while restricting visibility on a need-to-know basis. This single source of truth both speeds up and reduces risk to the tech transfer process, and its intended outcomes.
Come and join us at SLAS 2023 to learn how Polar can help you navigate your biopharma lifecycle
Come and join us at BPI West to learn how Polar can help you navigate you biopharma lifecycle and how Skyland PIMS can help accelerate your biopharma development and manufacturing.
Data silos and inconsistent data formats increase the chance of errors, which can have a significant impact on business operations. Digital workflows are the answer.
Explore how cloud-based solutions can improve data visibility and transparency so that partners can enjoy equal access to data at all stages of the BioPharma lifecycle.
Discover how a shared data backbone in tech transfer can remove inefficiencies and inconsistencies found in a one-time transfer approach.
Do you have a vision for clean, contextualized data? Is IT accountable to the bench in your lab? Are you willing to value even the most unassuming insights?
Maintaining the balance between compliance and efficiency is what will set a CRO apart in the highly competitive outsourcing landscape and inspire the sponsor’s confidence.
Drug sponsors value – and rely on – the work that CROs perform. CROs have a chance to up their data management game. How can they ensure data quality?
Learn the importance of enterprise control in getting CGTs to market – and the critical systems that enable this control in cell-based therapy manufacturing.
From ensuring data integrity to consolidating IP ownership, effective data management is key for BioPharma companies seeking a competitive edge.
Join us on the 30th November, to discuss best practices for addressing this challenge and explore the use of innovative solutions to streamline process data management with higher data integrity, support accelerated tech transfer between development and manufacturing, and drive collaboration among internal and external teams.
A cloud-only approach provides many benefits, including streamlined validation, automated backups and upgrades, faster deployments and flexibility.
A digital data backbone can improve efficiency in the research process leading to earlier discoveries and lower costs. Discover how now.
IDBS will be exhibiting in the event this year in Orlando, FL, at booth #1138. We look forward to seeing you there!
IDBS attended EBF in Barcelona. You can still book a meeting with one of our specialists.
Successful tech transfer can be a challenge, even for well-established biotechs. Here’s how to avoid common pitfalls at every stage.
Modernized data governance ensures a solid foundation of data integrity and compliance and achieves an integrated approach to the BioPharma data lifecycle.
Now that we know what a microservice is and why it’s important, let’s explore deploying and managing cloud microservices in GxP environments.
Speeding up time to insight throughout the BioPharma lifecycle requires all data sources to be connected and utilized to form a robust data backbone.
Join IDBS at booth E2 at the ELRIG conference in London, Europe’s largest meeting for life sciences industry professionals.
What is a microservice? Let’s explore the term’s meaning, the benefits and how it can help boost your data security.
Life science companies rely on data integrity, security and transparency to ensure success. How do we protect data while keeping it accessible?
BioProcess International took place in Vienna this year, with talks centred around six main streams including cell line development and engineering, cell culture, recovery and purification, viral safety, cell and gene therapy as well as smaller sessions for manufacturing strategy and Industry 4.0 and vaccine manufacturing.
IDBS, a global life sciences software company and the leading innovator in BioPharma Lifecycle Management (BPLM), is excited to bring together over 200 customers, partners and industry experts, including leading CxO and BioPharma companies, at their annual i3 user conference.
In the quest to develop the science and raise funding, developing a digital strategy in general is an afterthought for fledgling biotech companies – if it’s considered at all. Not paying attention to it early, however, can hamper their ability to advance their science and constrain their revenue-generation options.
IDBS will be presenting at the conference this year in Vienna. We look forward to being back at Bioprocess in-person events in 2022.
Modern BioPharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.
Gain key insights on the value of using purpose-built software systems to streamline your critical manufacturing data management and product quality processes across internal and external networks.
IDBS announces the latest release of its Skyland PIMS software, which seamlessly combines product, process, and patient data across the BioPharma life cycle and supply chain, providing insights that accelerate process understanding and ensure product quality.
It’s been a busy year so far. And we’re only at the start of April! Find out what we’ve been up to in this blog.
Book your meetings with IDBS and Scitara at the IOT & Smart Pharma Summit this year in San Diego, CA. We look forward to being back in person and virtually in 2022.
Accelerate process understanding and time-to-insight across your development and manufacturing lifecycle. Join us at booth #21 at the Biomanufacturing World Summit in San Diego, USA.
IDBS will be running our annual experience event, i3, again in June this year!
Compared to most other industries, life science and biopharmaceutical companies have been slow to embrace digital technologies. Why?
As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs?
IDBS will be presenting at the event this year in Boston. We look forward to seeing you there!
IDBS will be presenting at the conference this year in Atlanta, GA. We look forward to being back at WRIB in person in 2022.
IDBS will be running our annual experience event, i3, again in June this year!
IDBS will be presenting at the event this year in San Francisco, CA. We look forward to seeing you there!
The pandemic exposed the innovation divide between the digitally transformed and those that lagged. Strict regulation made life sciences and BioPharma organizations hesitant to modernize too quickly away from proven legacy methods and technologies, resulting in varying levels of digital transformation. But are they missing out?
Wondering if an ELN can be used as a LIMS? Hear from IDBS and other experts in this interesting piece published in Lab Manager.
Global life sciences software company, IDBS, is excited to publicly announce the location of our new Surrey HQ office address in Woking.
Join us for an interesting roundtable discussion around how to build a solid foundation for advanced analytics and why legacy ELN/LIMS aren’t suitable for modern biopharma because they don’t support the data backbone concept. Hear from experts at Accenture, GSK and IDBS and gather insight from experiences close to the ever evolving market.
Throughout the past few years, there’s been a clear trend in the makeup of approvals, with biologics representing a growing percentage. But even within biologics, newer technologies like mRNA, cell, and gene therapies are gaining ground. The approvals are not one-off events, but evidence of an exciting long-term trend. Learn more from Christian Marcazzo, General Manager at IDBS, in his article published in Drug Development & Discovery.
IDBS will be presenting at the event this year in Berlin, Germany. We look forward to seeing you there!
A top ten CRO (Contract Research Organization) has chosen IDBS’ Polar™ BioPharma Lifecycle Management to achieve its goal of faster biopharma development.
IDBS will be presenting at the conference this year in Boston, MA. We look forward to being back at Bio-IT in person and virtually in 2022.
Around this time last year, the first COVID-19 vaccines were authorized for emergency use. A year before that, COVID-19 had not yet been declared a pandemic. It goes to show how much can change in this industry, as well as how important this sector is. Hear predictions from experts, including Alberto Pascual, in this article, published in Drug Discovery World.
For those of us who develop software that supports the biopharmaceutical/life science industry, the challenges and opportunities in digital transformation are painfully obvious and it can be easy to forget that not everyone sees it that way. Let’s try another way…
IDBS will be presenting at the conference this year in San Diego, California. We look forward to being back at Bioprocess in-person events in 2022.
This webinar will discuss the progress made in the operational analytics and data space and the real benefits to its system administrators and speadsheet data consumers. E-WorkBook Cloud and Polar customers will learn about the capabilities available to them. And E-WorkBook on-premise customers will learn about some business benefits of migrating to the cloud as well.
While 2021 was another challenging year in many respects, the life science industry still managed some notable achievements.
Tomorrow’s Connection Today – Designing a new future for manufacturing, quality and supply chain leaders. We will be attending the European Biomanufacturing Summit virtual conference on February 8-10, 2022.
Watch our webinar, Managing the Journey from Process Development to Insight, where you will learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize cell culture productivity, and discover how digital workflows with embedded integrations can curate a process data backbone that speeds time-to-insight with advanced data analytics and visualization tools.
Join Henry Charlton, Commercial Director Biologics to learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize productivity, and discover how digital workflows with embedded integrations can curate a process data backbone that speeds time-to-insight and time to commercial readiness with advanced data analytics and visualization tools.
IDBS, a global life sciences software company and Synthace, a pioneer software for automated biology experimentation and insight sharing, have entered a strategic partnership to provide IDBS Polar users with state-of-the-art data foundations for experimentation in high-throughput process development (HTPD).
IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform. Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.
Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing.
Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing. Skyland Analytics is best known for its Skyland PIMS™ software which seamlessly combines product, process, and patient data across the biopharma lifecycle and supply chain, providing insights that accelerate process understanding and ensure product quality.
When you factor in the unpredictability and complexity of therapies like biologics, the time impacts of poorly managed data are on the order of 6–18 months. Find out more on why legacy data management systems can’t support the directions…
IDBS will have a booth at the 14th Annual European BioAnalysis Forum in Barcelona.
The global community await to hear what the accelerated response to climate change will be from the COP26 Summit starting on Sunday in Glasgow. Here at IDBS we know that identification of true reductions in environmental impact through process modelling and Life Cycle Assessment can only be made with access to quality data. Find out more in our blog.
Join over 400 scientific leaders at Cell UK: In-Person Congress, connecting regenerative medicine and bioprocessing experts to transform cell research and therapies.
IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), announces its membership of BioPhorum. BioPhorum offers a space where biopharmaceutical manufacturers and suppliers can come together and discuss the many challenges in the industry, working collaboratively to address them. IDBS has joined the Information Technology Phorum (BPIT) which specifically addresses IT business goals.
Europe’s leading bioprocessing event for accelerating biologics, mAbs, vaccines and novel products to commercial success. Access leading science, technologies and contacts across the entire bioprocessing spectrum.
i3 our premier annual event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation and this year we went virtual. During i3 you will gain insights from your peers using…
The biopharma industry may have been slow to embrace digital technologies, but it’s catching up fast. The innovation we’re seeing in predictive modeling and machine learning could truly revolutionize the entire lifecycle of drug discovery and development. Take a…
India Digital R&D Lab Summit” is our premier annual event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation!
Life sciences companies are using digital twins for everything from drug discovery to manufacturing. Hear from a panel of experts at MedCity News’ INVEST Digital Health conference, moderated by Accenture, where companies, including IDBS, discuss how this capacity to…
This session will provide an overview of IDBS’s upcoming plans to embed the DLX platform within E-WorkBook Cloud to provide a scalable, enterprise-grade integration backbone for lab connectivity and workflow orchestration. Following the overview, there will be an open forum to discuss some of the challenges in delivering lab integration at scale and feedback on workflows / instrument classes that should be considered for initial prioritization.
IDBS is excited for its upcoming analytics launch and will update attendees to the progress made in this space which will have real benefits to its system administrators and spreadsheet data consumers. E-WorkBook Cloud and Polar customers will learn about new capabilities soon available to them – and E-WorkBook on-premise customers will learn about some business benefits of migrating to the cloud.
Join IDBS’ Alberto Pascual for this roundtable discussion, The Role of Digital Twins in Life Sciences, at the MedCity INVEST Digital Health virtual conference.
In the biopharmaceutical industry, there’s no shortage of data—the issue organizations more often face is how to capture data in ways that derive insight from it. As more and more companies are now recognizing, a fundamentally different approach is…
IDBS, a leading R&D technology and solutions provider and Tableau, the world’s leading analytics platform, announced a strategic partnership to integrate Tableau into the IDBS suite of products. The collaboration will be based on embedding Tableau’s visual and analytics capabilities into the IDBS product offerings.
Roundtable Discussion | IDBS Hosts the Best Practices in Bioanalysis Lab Informatics. Hear how industry experts like Nexelis, AbbVie, and ICON plc are tackling digital lab challenges
Danaher Chief Science Officer Jose-Carlos Gutierrez-Ramos explores how the biopharma rule book has been rewritten by the pandemic and what to expect from the future of genomic medicines in this exclusive new article for Pharmaceutical Executive magazine…
Alberto Pascual, IDBS, tells MedCity News how digital twins can help advance innovation in R&D…
There was a flurry of activity on social media in June when John Erickson et al. published in Biotechnology and Bioengineering on end-to-end collaboration to transform development and manufacturing of biopharmaceuticals.
i3 is our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation!
Efficient data management is critical to meet the demand for fast drug development – especially today…
In this webinar IDBS will share how an innovative approach to biopharma lifecycle management supports true QbD and can accelerate development to bring products to market faster.
One of the lasting legacies of the COVID-19 pandemic is heightened awareness of manufacturing challenges and supply chain vulnerabilities in the biopharma industry and the impact this can have on public health. Issues have occurred at every stage of the supply chain, from the availability of raw materials to quality concerns with active pharmaceutical ingredients (APIs), and finished dosage forms and restrictive cold chain requirements.
Join Alberto Pascual, IDBS’s Director of Data Science and Analytics where he will discussing how you can join the digital transformation revolution by democratizing the use of advance analytics!
In a recent Forbes article, Danaher’s Chief Science officer, Jose-Carlos Gutierrez-Ramos, described the impact of the COVID-19 pandemic as follows:“I believe the biopharma business model has fundamentally changed.
IDBS has always listened to its customers and used the feedback gathered to guide the development of product capabilities. In fact, it is one of Danaher’s core values. Being part of Danaher’s Life Sciences arm has reaffirmed the value and we are constantly looking to improve based on customers’ feedback.
IDBS are delighted to presenting at The 2nd Quality Science of Biologics Summit in Beijing on the 25th May. We hope to see you there!
Biopharma 4.0 is a bold vision, with smart factories and process automation, driven by real time data to constantly ensure quality and efficiency. The journey towards this vision starts with improving process understanding and characterization, supported by advances in…
In this webinar, Henry Charlton, Commercial Director of Biologics Development at IDBS will share how effective biopharma lifecycle management can drive speed and innovation in process development as labs struggle with the increases in data from equipment, instruments and sensors.
A Week of Bioanalysis, Biomarkers, Immunogenicity, Gene Therapy, Cell Therapy & Vaccines
Meet us virtually for the 15th WRIB Annual Conference where high quality, better compliance to regulations and scientific excellence have always been the foundations of WRIB.
The public consciousness has been flooded with awareness of the previously niche concerns of quality control in drug manufacturing.
TetraScience, the world’s first and only open R&D Data Cloud for scientific discovery, and IDBS, a leading R&D technology and solutions provider, announce a strategic partnership to integrate IDBS E-WorkBook and Tetra Data Platform into a common ecosystem to provide end-to-end R&D data automation.
LabVoice, which provides a workflow engine for scientific voice assistants, and IDBS, a leading R&D technology and solutions provider, are excited to announce an integration to accelerate research, innovation, and design.
IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), today announced the launch of Polar BioAnalysis, bringing consistency, quality, and reproducibility to preclinical drug qualification.
Asia’s leading bioprocessing event for learning how to drive down costs, improve timelines, and navigate the regulatory landscape for your biologics and novel modalities.
Learn How BioProcessing Experts are Increasing Quality, Process Efficiency and Productivity While Decreasing Costs to Achieve Commercial Success
Join Henry Charlton, Commercial Director, Biologics Development for for IDBS, at 11:00 am (JST) on April 6th to hear about the bold Biopharma 4.0 vision. Learn how to accelerate your cell culture development with biopharma lifecycle management.
The leading virtual event for learning how to improve process efficiencies and maintain product quality across all phases of bioprocessing.
Join Unjulie Bhanot, Solution Owner for IDBS, at 11:55 am PST on March 31 to hear about the bold Biopharma 4.0 vision. Learn how to accelerate your cell culture development with biopharma lifecycle management.
The global pandemic is shining a spotlight on the power of biologics, both vaccines and antibody therapeutics, to prevent serious infections and treat disease.
The licensing and integration of Scitara DLX technology will offer IDBS users plug-and-play connectivity to any instrument or application in regulated and non-regulated laboratories
The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA — January 12, 2021 — Genedata and IDBS, both…
Guildford, UK and Framingham, MA, September 9th, 2020 – IDBS announced today that it has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst® Software, expanding IDBS’s existing family of integrations. This new…
The ultimate goal in the biopharma space, especially for vaccine manufacturers, is producing safe and effective therapies faster, and at a lower cost. Many professionals still believe that their competitive edge relies on technical improvement, but it’s more complicated than that…
Join us at EBF, for the 14th meeting, focussing on the power of Science as our universal language. You can find us at the exhibit in the main conference expo hall, or catch one of our luncheon presentations. EBF 2020…
Join us at PEGS Boston, the leading conference & expo where world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions convene every year to transform the future of biologics. You can find us at the exhibit…
In response to the outbreak, governments around the world have put strict measures in place to limit the spread of the virus – Italy was the first country to order a country-wide lock down, France closed its borders and PM…
A Week of Bioanalysis, Biomarkers, Immunogenicity, Gene Therapy & Vaccine Assays High quality, better compliance to regulations and scientific excellence are always the foundations of this workshop. IDBS helps deliver consistency, quality and reproducibility for Preclinical…
Join us at Bio-IT World 2020, the leading conference and expo uniting life science, data, informatics, and IT leaders. You can find us at exhibit #326 in the main conference expo hall, or catch one of our luncheon presentations…
The Leading International Composites Show The JEC Group decided to postpone the 2020 edition of JEC World from May 12-14, 2020 to March 9-11, 2021. JEC Group is the world’s leading company dedicated entirely to the development of information…
BioAsia 2020 explores the capabilities that Life sciences companies should invest in today to thrive and create value tomorrow. Globally, the rise of more informed healthcare consumers, new technologies, and ubiquity of data and analytics continues to blur the…
Increase efficiency, enhance connectivity and drive superior quality in the modern lab. We’re delighted to be partnering with IQPC again in 2020 to bring you SmartLab Digital on 11th and 12th March. SmartLab Digital is a complimentary online series…
Join us at Analytica 2020, the world’s leading trade fair for laboratory technology, analysis, biotechnology and analytica conference. You’ll find us sharing booth space with our fellow Danaher operating companies Molecular Devices and Pall in Hall A3 covering Biotechnology…
IDBS, a software informatics solution provider for biotech and pharma, has expanded its global reach in India and made two strategic hires in the region. The latest move by the firm is in response to growing demand and an expanding…
In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’, have rapidly become an integral part of the R&D programs of many Biopharmaceutical companies. This is illustrated by some of the key trends…
Western CROs continue to up their game. They are offering unique services in a marketplace where the big CROs of the east are providing an unsurpassed scale of resourcing to support the externalization of discovery services. I believe there is…
This year BioProduction Congress merges with bioLIVE to become BioProduction at CPhI Worldwide. BioProduction will be co-located with CPhI Worldwide in Frankfurt, 5th-7th November 2019 – the largest pharmaceutical event in the world – uniting biotech, pharma, and solution…
Want to know a secret? In September we hosted a very large group of IDBS customers from the US at i3 Nashville. Customers from every R&D industry sharing experiences, lessons learned, and business challenges. So, are you going to…
We sat down with Chelsea Hyde, Field Marketing Manager for North America at IDBS, to find out what i3 means to IDBS, and what to expect at future events. What does i3 mean? When we were coming up with…
IDBS becomes the first Electronic Lab Notebook provider to achieve SOC 2 compliance IDBS has achieved compliance with SOC 2, following an audit by CyberGuard Compliance, LLC to the American Institute of Certified Public Accountants’ (AICPA) Trust Services Criteria…
We sat down with Christian Marcazzo, General Manager at IDBS, to find out what the benefits of attending i3 are, and how it fits into his vision for IDBS. What are some of the benefits to customers attending the i3…
The biopharmaceutical industry continues to grow and isn’t showing any signs of slowing down. Last year, we talked about different aspects of the biopharmaceutical industry. These touched on several trends from the importance of data and the extensive use…
IDBS enables research and innovation (R&I) teams to accelerate data capture, analysis and scientific decision-making and reduce the time to market of innovative, cost-effective new products to millions of customers worldwide. You can find out more about our approach to…
We sat down with J.T. Kaminski, Customer Success Manager at IDBS, to find out what i3 means to IDBS, and what he sees for the event’s future. What’s the most eye-opening thing you’ve seen at i3 last year? I’d…
Eighty-five. That’s the number of warning letters the FDA issued in 2018 alone. And of those letters, 49% were surrounding data integrity. This highlights a serious issue: there are data integrity deficiencies in the lab environment. With so many warning…
We sat down with Brady Haggstrom, Product Manager at IDBS, to find out what i3 means, and its highlights. What do you look forward to most about coming to i3 events? I look forward most to talking with customers and hearing about their challenges, what…
In our last blog post, we took a dive into the 2019 draft of the ICH M10 Bioanalytical Method Validation Guideline, the changes made, and how they affect scientists working at the bench. In this follow-up post, we’ll see…
The International Council of Harmonisation (ICH) has released a draft new guidance for bioanalytical method validation, and it has created quite a buzz, exemplified in a webinar hosted by Bioanalysis Zone. A panel of experts came together to discuss…
Historically, small molecule pharmaceutical products dominated the medical drugs market, from treatments for diabetes to broad-spectrum antibiotics, they worked, and the pharma industry bloomed. However, in today’s day and age, as the prevalence of different types of diseases and…
The latest version of ActivityBase and ActivityBase XE version 9.5 has been released to customers. This forms part of IDBS’ regular bi-annual product release and continues our investment into ActivityBase, supporting our large top pharma and biotech customer base. Over…
The importance of data integrity The research and development (R&D) industry has a responsibility to ensure the drugs they produce are safe, effective and high quality, and data integrity is key to making that happen. But it’s not always…
When you think of a medication, is the active ingredient the first thing that pops into your head, or perhaps the name of the drug? You’re not alone. The active ingredient of a medicine gets all the attention, which…
Writing for Scientific Computing World, Graeme Dennis says we should move away from the traditional definitions of informatics software. You can read the article here.About IDBSContact us More news…
In an online exclusive for EPM, Brady Haggstrom, IDBS, looks at the changing landscape of drug development and delivery, which is more and more outsourced nowadays, and how technology can help protect sensitive research data. Read the article here.About IDBSContact…
Science is based on evidence, but the scientific research field is facing a reproducibility crisis. The science journal Nature published a survey in 2016, which demonstrated more than 70% of researchers could not replicate their peers’ studies in well-controlled…
Getting a product to market has always been a challenge. Discovering something new is just the beginning. After that, there’s the issue of securing the funding to bring the idea to life – the research, manufacturing processes, and pushing it…
The biologics market – medicines made from biological living systems through biotechnology – is trending. There’s no doubt about that. And the numbers back it up. According to a report by Market Research Future, the global biologics market…
Organizations in the biologics landscape face several challenges in the race to get their product to market, including handling their data efficiently. We have a solution… Industry growth presents challenges The continued growth in the biologics sector has…
When one thinks of the pharma and biopharma markets, one thing stands out – growth. In recent years, driven by necessity, advances in technology and ultimately funding, there has been a focused effort to transform our approach to medicine…
E-WorkBook is an electronic lab notebook that forms part of the IDBS cloud-based solution to manage your scientific data. Designed to replace the traditional paper lab notebook, information is stored electronically and so can be accessed and searched effortlessly…
We are just two weeks away from our Early Bird deadline for tickets to our i3 events in Nashville and London this year. Book before 31st May and you’ll get 40% off our Standard or All Access Passes. Don’t…
The biologics landscape is modern and ever-changing – and it needs innovative solutions to keep up with growing demand. What’s needed is a far-reaching and comprehensive solution, that helps scientists effortlessly execute workflows and provides decision-driving insight. We…
IDBS will be exhibiting at the Hesperia Hotel in Barcelona on the 20-22 November. We will be showcasing how our Bioanalysis Solution could help you at booth B22. The IDBS Bioanalysis Solution provides a complete suite of interconnected workflows…
Without heavy investment in research and development (R&D), the millions of new and innovative medical technologies, drugs and delivery systems developed each year would simply not happen. In 2018, the UK’s medical funding body – the Medical Research Council…